Plain-English translation of NCT05582200 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This research study is testing a new brain imaging method called 18F-SMBT-1 PET scanning to better detect and measure inflammation in the brains of people with Alzheimer's disease. Inflammation in the brain plays an important role in Alzheimer's, but current imaging methods cannot clearly tell which types of brain cells are causing it. This study hopes to develop a clearer picture of what's happening in the brain during Alzheimer's disease.
Scientists know that brain inflammation is involved in Alzheimer's disease, but current imaging tools are limited and can't distinguish between different types of brain cells causing the inflammation. This research aims to create a better, more specific imaging method to understand inflammation in Alzheimer's and potentially help doctors diagnose and treat the disease earlier.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will come in for brain imaging visits where you'll have PET and MRI scans performed. Some participants may also have a scan where a medication is given to block certain brain activity, allowing doctors to measure how the imaging tracer works. The study involves comparing brain scans between people with Alzheimer's disease and healthy volunteers to see how inflammation differs between the two groups. The entire process may take place over several visits, and you will receive detailed information about what to expect during each appointment.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
United States